Ionis Pharmaceuticals Stock Market Value
| IONS Stock | USD 80.60 1.18 1.44% |
| Symbol | Ionis |
Is there potential for Biotechnology market expansion? Will Ionis introduce new products? Factors like these will boost the valuation of Ionis Pharmaceuticals. Market participants price Ionis higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about Ionis Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.44) | Earnings Share (1.61) | Revenue Per Share | Quarterly Revenue Growth 0.171 | Return On Assets |
Understanding Ionis Pharmaceuticals requires distinguishing between market price and book value, where the latter reflects Ionis's accounting equity. The concept of intrinsic value - what Ionis Pharmaceuticals' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Ionis Pharmaceuticals' price substantially above or below its fundamental value.
Please note, there is a significant difference between Ionis Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ionis Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Ionis Pharmaceuticals' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Ionis Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Ionis Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Ionis Pharmaceuticals.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in Ionis Pharmaceuticals on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Ionis Pharmaceuticals or generate 0.0% return on investment in Ionis Pharmaceuticals over 90 days. Ionis Pharmaceuticals is related to or competes with Ascendis Pharma, BridgeBio Pharma, Revolution Medicines, Roivant Sciences, Summit Therapeutics, Biomarin Pharmaceutical, and Exelixis. Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States More
Ionis Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Ionis Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Ionis Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.7 | |||
| Information Ratio | 0.0899 | |||
| Maximum Drawdown | 8.08 | |||
| Value At Risk | (2.67) | |||
| Potential Upside | 3.62 |
Ionis Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ionis Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Ionis Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Ionis Pharmaceuticals historical prices to predict the future Ionis Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.1078 | |||
| Jensen Alpha | 0.1733 | |||
| Total Risk Alpha | 0.0898 | |||
| Sortino Ratio | 0.1012 | |||
| Treynor Ratio | 0.2375 |
Ionis Pharmaceuticals February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1078 | |||
| Market Risk Adjusted Performance | 0.2475 | |||
| Mean Deviation | 1.57 | |||
| Semi Deviation | 1.49 | |||
| Downside Deviation | 1.7 | |||
| Coefficient Of Variation | 790.62 | |||
| Standard Deviation | 1.91 | |||
| Variance | 3.65 | |||
| Information Ratio | 0.0899 | |||
| Jensen Alpha | 0.1733 | |||
| Total Risk Alpha | 0.0898 | |||
| Sortino Ratio | 0.1012 | |||
| Treynor Ratio | 0.2375 | |||
| Maximum Drawdown | 8.08 | |||
| Value At Risk | (2.67) | |||
| Potential Upside | 3.62 | |||
| Downside Variance | 2.89 | |||
| Semi Variance | 2.23 | |||
| Expected Short fall | (1.75) | |||
| Skewness | 0.1835 | |||
| Kurtosis | (0.67) |
Ionis Pharmaceuticals Backtested Returns
Currently, Ionis Pharmaceuticals is very steady. Ionis Pharmaceuticals holds Efficiency (Sharpe) Ratio of 0.0808, which attests that the entity had a 0.0808 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Ionis Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please check out Ionis Pharmaceuticals' Risk Adjusted Performance of 0.1078, market risk adjusted performance of 0.2475, and Downside Deviation of 1.7 to validate if the risk estimate we provide is consistent with the expected return of 0.14%. Ionis Pharmaceuticals has a performance score of 6 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 0.98, which attests to possible diversification benefits within a given portfolio. Ionis Pharmaceuticals returns are very sensitive to returns on the market. As the market goes up or down, Ionis Pharmaceuticals is expected to follow. Ionis Pharmaceuticals right now retains a risk of 1.79%. Please check out Ionis Pharmaceuticals maximum drawdown, as well as the relationship between the skewness and day typical price , to decide if Ionis Pharmaceuticals will be following its current trending patterns.
Auto-correlation | -0.12 |
Insignificant reverse predictability
Ionis Pharmaceuticals has insignificant reverse predictability. Overlapping area represents the amount of predictability between Ionis Pharmaceuticals time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Ionis Pharmaceuticals price movement. The serial correlation of -0.12 indicates that less than 12.0% of current Ionis Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.12 | |
| Spearman Rank Test | 0.2 | |
| Residual Average | 0.0 | |
| Price Variance | 5.92 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Ionis Stock Analysis
When running Ionis Pharmaceuticals' price analysis, check to measure Ionis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ionis Pharmaceuticals is operating at the current time. Most of Ionis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ionis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ionis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ionis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.